Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative Conditioning with TBI vs Fludarabine/TBI for HCT in Hematologic Malignancies
NCT00075478Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Oct 2003
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 3 trial of fludarabine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), chronic myelogenous leukemia (CML), diffuse large B-cell lymphoma (DLBCL), sponsored by Fred Hutchinson Cancer Center. Started Oct 2003; status: completed.
02
Drugs
fludarabine
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)non-Hodgkin lymphoma (NHL)chronic myelogenous leukemia (CML)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00075478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075478.